Panes J, et al. - The physicians aimed to determine the long-term efficacy and safety of a single local administration of allogeneic expanded adipose-derived stem cells (Cx601) in patients with Crohn’s disease (CD) and perianal fistulas. Compared with placebo, Cx601 was found to be safe and effective in closing external openings after 1 year.